KMT2A and acute myeloid leukemia: MLL-AF9 can transform both hematopoietic stem and progenitor cells, giving rise to very aggressive or a somewhat more slowly progressing AML-like disease, respectively, upon transplantation into congenic recipient mice [30, 31, 41].